Literature DB >> 31951490

Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.

Venkatesan Chakrapani1,2, Murali Shunmugam1, Shruta Rawat2, Dicky Baruah2, Ruban Nelson1, Peter A Newman3.   

Abstract

Despite high HIV prevalence among transgender women (TGW) in India, there is limited exploration of pre-exposure prophylaxis (PrEP) acceptability. With PrEP licensure pending, we conducted six focus group discussions (FGDs) with diverse TGW (n = 36), and eight key informant interviews with community leaders and physicians, in Mumbai and Chennai. Data were explored using framework analysis guided by the Theoretical Framework of Acceptability. FGD participants' mean age was 26.1 years (SD = 4.8); two-thirds engaged in sex work. TGW reported low PrEP awareness, with moderate acceptability once PrEP was explained. Population-specific facilitators of PrEP acceptability included its perceived effectiveness in the context of challenges to condom use in serodiscordant relationships and forced sex encounters. PrEP was considered especially appropriate for TGW sex workers; however, barriers were anticipated in the context of hierarchical hijra (indigenous trans identity) kinship networks and gurus' (masters) potential negative reactions to PrEP use by their chelas (disciples). Positive attitudes toward high efficacy and potential covert use were tempered by TGW's concerns about high costs and adherence challenges living with parents or primary partners, and TGW sex workers' unpredictable schedules. Anticipated interactions with feminizing hormones, visible side effects, and PrEP-related stigma within TGW communities emerged as opportunity costs. PrEP implementation for TGW in India should promote comprehensive information on side effects and potential interactions with feminizing hormones, provide free or subsidized PrEP, and highlight the advantages of added protection in sex work and forced sexual encounters. Meaningful engagement with TGW kinship networks can encourage positive transgender community norms on PrEP use and mitigate multifaceted stigma.

Entities:  

Keywords:  HIV prevention; India; PrEP; sex workers; transgender persons

Mesh:

Substances:

Year:  2020        PMID: 31951490      PMCID: PMC7611172          DOI: 10.1089/apc.2019.0237

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  26 in total

1.  HIV Pre-exposure Prophylaxis Indication and Readiness Among HIV-Uninfected Transgender Women in Ho Chi Minh City, Vietnam.

Authors:  Catherine E Oldenburg; Bao Le; Trang Toan; Dinh Duc Thien; Hoang Thi Huyen; Mackey R Friedman; Ron Stall; Donn Colby
Journal:  AIDS Behav       Date:  2016-12

Review 2.  Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care.

Authors:  Andrew Silapaswan; Douglas Krakower; Kenneth H Mayer
Journal:  J Gen Intern Med       Date:  2016-10-19       Impact factor: 5.128

3.  Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.

Authors:  Jean-Michel Molina; Isabelle Charreau; Bruno Spire; Laurent Cotte; Julie Chas; Catherine Capitant; Cecile Tremblay; Daniela Rojas-Castro; Eric Cua; Armelle Pasquet; Camille Bernaud; Claire Pintado; Constance Delaugerre; Luis Sagaon-Teyssier; Soizic Le Mestre; Christian Chidiac; Gilles Pialoux; Diane Ponscarme; Julien Fonsart; David Thompson; Mark A Wainberg; Veronique Doré; Laurence Meyer
Journal:  Lancet HIV       Date:  2017-07-23       Impact factor: 12.767

4.  'WTF is PrEP?': attitudes towards pre-exposure prophylaxis among men who have sex with men and transgender women in New York City.

Authors:  Matthew Thomann; Ashley Grosso; Richard Zapata; Mary Ann Chiasson
Journal:  Cult Health Sex       Date:  2017-10-06

5.  Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation.

Authors:  Venkatesan Chakrapani; Peter A Newman; Murali Shunmugam; Shruta Mengle; Jarvis Varghese; Ruban Nelson; Shalini Bharat
Journal:  AIDS Patient Care STDS       Date:  2015-09-08       Impact factor: 5.078

6.  Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure Prophylaxis.

Authors:  Mackenzie L Cottrell; Heather M A Prince; Amanda P Schauer; Craig Sykes; Kaitlyn Maffuid; Amanda Poliseno; Tae-Wook Chun; Erin Huiting; Frank Z Stanczyk; Anne F Peery; Evan S Dellon; Jessica L Adams; Cindy Gay; Angela D M Kashuba
Journal:  Clin Infect Dis       Date:  2019-11-27       Impact factor: 9.079

7.  Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada.

Authors:  Peter A Newman; Adrian Guta; Ashley Lacombe-Duncan; Suchon Tepjan
Journal:  J Int AIDS Soc       Date:  2018-11       Impact factor: 5.396

8.  Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.

Authors:  Luis Sagaon-Teyssier; Marie Suzan-Monti; Baptiste Demoulin; Catherine Capitant; Nicolas Lorente; Marie Préau; Marion Mora; Daniela Rojas Castro; Christian Chidiac; Julie Chas; Laurence Meyer; Jean-Michel Molina; Bruno Spire
Journal:  AIDS Care       Date:  2016-02-17

9.  Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India.

Authors:  Kenneth H Mayer; Nomita Chandhiok; Beena Thomas
Journal:  Indian J Med Res       Date:  2016-02       Impact factor: 2.375

Review 10.  Global Epidemiology of HIV Infection and Related Syndemics Affecting Transgender People.

Authors:  Tonia Poteat; Ayden Scheim; Jessica Xavier; Sari Reisner; Stefan Baral
Journal:  J Acquir Immune Defic Syndr       Date:  2016-08-15       Impact factor: 3.731

View more
  6 in total

1.  Willingness to Use Pre-exposure Prophylaxis (PrEP) and Preferences Among Men Who have Sex with Men in Mumbai and Chennai, India: A Discrete Choice Experiment.

Authors:  Venkatesan Chakrapani; Peter A Newman; Michael Cameron; Murali Shunmugam; Surachet Roungprakhon; Shruta Rawat; Dicky Baruah; Ruban Nelson; Suchon Tepjan; Riccardo Scarpa
Journal:  AIDS Behav       Date:  2021-04-05

Review 2.  Increasing awareness of HIV pre-exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta-analysis of global data.

Authors:  Zhishan Sun; Qianfei Gu; Yifan Dai; Huachun Zou; Bruce Agins; Qiaosen Chen; Peiyang Li; Junchun Shen; Yi Yang; Hongbo Jiang
Journal:  J Int AIDS Soc       Date:  2022-03       Impact factor: 5.396

3.  Factors Influencing Willingness to Use Human Immunodeficiency Virus Preexposure Prophylaxis Among Transgender Women in India.

Authors:  Venkatesan Chakrapani; Simran Shaikh; Visvanathan Arumugam; Umesh Chawla; Sonal Mehta
Journal:  Transgend Health       Date:  2021-04-16

4.  Mapping Interests in Event-Driven and Long-Acting Pre-exposure Prophylaxis Formulations onto the HIV Risk Environment of Street-Based Female Sex Workers: A Latent Class Analysis.

Authors:  Joseph G Rosen; Ju Nyeong Park; Kristin E Schneider; Rebecca Hamilton White; S Wilson Beckham; Jennifer L Glick; Katherine H A Footer; Susan G Sherman
Journal:  AIDS Behav       Date:  2022-04-01

5.  Acceptability of daily pre-exposure prophylaxis among adolescent men who have sex with men, travestis and transgender women in Brazil: A qualitative study.

Authors:  Eliana Miura Zucchi; Marcia Thereza Couto; Marcelo Castellanos; Érica Dumont-Pena; Dulce Ferraz; Thiago Félix Pinheiro; Alexandre Grangeiro; Luís Augusto Vasconcelos da Silva; Inês Dourado; Leo Pedrana; Fernanda Soares de Resende Santos; Laio Magno
Journal:  PLoS One       Date:  2021-05-04       Impact factor: 3.240

6.  Transgenders are the most vulnerable amongst individuals engaging in receptive anal intercourse: A cross-sectional study from North India.

Authors:  Tanvi Arora; Neelam Wadhwa; Deepika Pandhi; Preeti Diwaker; Vinod K Arora
Journal:  J Family Med Prim Care       Date:  2021-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.